Zebrafish as a preclinical model for diabetes mellitus and its complications: From monogenic to gestational diabetes and beyond

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

Figures (1-4)

Tables (1-3)

Sum=22

May 15, 2025 (publication date) through Apr 25, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Diabetes. May 15, 2025; 16(5): 100574
Published online May 15, 2025. doi: 10.4239/wjd.v16.i5.100574

Full Size Figure Download Figure

Figure 2 Drug modification approaches for inducing β-cell regeneration. DMFO: Difluoromethylornithine; STZ: Streptozotocin.

Citation: Huang J, Chen YL. Zebrafish as a preclinical model for diabetes mellitus and its complications: From monogenic to gestational diabetes and beyond. World J Diabetes 2025; 16(5): 100574
URL: https://www.wjgnet.com/1948-9358/full/v16/i5/100574.htm
DOI: https://dx.doi.org/10.4239/wjd.v16.i5.100574